Liu C - Search Results

1

Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer.

Lu Y, Liu C, Wang X, Liu L, Zhao Z, Liang Z, Liu Y, Wen Z, Du Q, Liu W. Lu Y, et al. Among authors: liu y, liu l, liu c, liu w. Eur J Med Chem. 2023 May 5;253:115324. doi: 10.1016/j.ejmech.2023.115324. Epub 2023 Mar 30. Eur J Med Chem. 2023. PMID: 37019030

2

In vitro efficacy of immuno-chemotherapy with anti-EGFR human Fab-Taxol conjugate on A431 epidermoid carcinoma cells.

Wang X, Zhu J, Zhao P, Jiao Y, Xu N, Grabinski T, Liu C, Miranti CK, Fu T, Cao BB. Wang X, et al. Among authors: liu c. Cancer Biol Ther. 2007 Jun;6(6):980-7. doi: 10.4161/cbt.6.6.4197. Epub 2007 Mar 26. Cancer Biol Ther. 2007. PMID: 17534145 Free article.

3

Rheological Law and Mechanism for Superplastic Deformation of Ti-6Al-4V.

Liu C, Zhou G, Wang X, Liu J, Li J, Zhang H, Chen L. Liu C, et al. Among authors: liu j. Materials (Basel). 2019 Oct 26;12(21):3520. doi: 10.3390/ma12213520. Materials (Basel). 2019. PMID: 31717796 Free PMC article.

4

Recent advances in two-dimensional materials for hydrovoltaic energy technology.

Liu Z, Liu C, Chen Z, Huang H, Liu Y, Xue L, Sun J, Wang X, Xiong P, Zhu J. Liu Z, et al. Among authors: liu y, liu c. Exploration (Beijing). 2023 Jan 28;3(2):20220061. doi: 10.1002/EXP.20220061. eCollection 2023 Apr. Exploration (Beijing). 2023. PMID: 37324031 Free PMC article. Review.

5

Bio-inspired Double Angstrom-Scale Confinement in Ti-deficient Ti_0.87 O₂ Nanosheet Membranes for Ultrahigh-performance Osmotic Power Generation.

Liu C, Ye C, Zhang T, Tang J, Mao K, Chen L, Xue L, Sun J, Zhang W, Wang X, Xiong P, Wang G, Zhu J. Liu C, et al. Angew Chem Int Ed Engl. 2024 Jan 22;63(4):e202315947. doi: 10.1002/anie.202315947. Epub 2023 Dec 20. Angew Chem Int Ed Engl. 2024. PMID: 38059770

6

Novel disulfide bond bridged 7-ethyl-10-hydroxyl camptothecin-undecanoic acid conjugate/human serum albumin nanoparticles for breast cancer therapy.

Zhang Y, Wang J, Liu C, Xing H, Jiang Y, Li X. Zhang Y, et al. Among authors: liu c. J Mater Chem B. 2023 Mar 15;11(11):2478-2489. doi: 10.1039/d2tb02506j. J Mater Chem B. 2023. PMID: 36843543

7

Enhanced immunogenicity induced by mRNA vaccines with various lipid nanoparticles as carriers for SARS-CoV-2 infection.

Zhang Y, Wang J, Xing H, Liu C, Zha W, Dong S, Jiang Y, Li X. Zhang Y, et al. Among authors: liu c. J Mater Chem B. 2023 Aug 9;11(31):7454-7465. doi: 10.1039/d3tb00303e. J Mater Chem B. 2023. PMID: 37448376

8

Reduction-Responsive Docetaxel Prodrug Encapsulated within Human Serum Albumin Nanoparticles for Cancer Therapy.

Zhang Y, Zhang H, Wang J, Liu C, Xing H, Jiang Y, Li X. Zhang Y, et al. Among authors: liu c. Mol Pharm. 2023 May 1;20(5):2513-2526. doi: 10.1021/acs.molpharmaceut.2c01107. Epub 2023 Apr 18. Mol Pharm. 2023. PMID: 37071030

9

Trivalent mRNA Vaccine against SARS-CoV-2 and Variants with Effective Immunization.

Wang J, Zhang Y, Liu C, Zha W, Dong S, Wang Y, Jiang Y, Xing H, Li X. Wang J, et al. Among authors: liu c. Mol Pharm. 2023 Oct 2;20(10):4971-4983. doi: 10.1021/acs.molpharmaceut.2c00860. Epub 2023 Sep 12. Mol Pharm. 2023. PMID: 37699256

10

Paclitaxel prodrug-encapsulated polypeptide micelles with redox/pH dual responsiveness for cancer chemotherapy.

Liu J, Zhang Y, Liu C, Jiang Y, Wang Z, Li X. Liu J, et al. Among authors: liu c. Int J Pharm. 2023 Oct 15;645:123398. doi: 10.1016/j.ijpharm.2023.123398. Epub 2023 Sep 9. Int J Pharm. 2023. PMID: 37690658

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79,998 results

Search Page

Filters